Compass Therapeutics, Inc.

Historical 13F Holders

Symbol
CMPX
CUSIP
20454B104
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 21 8.69 M $16.5 M
2024 Q4 92 101 M $147 M
2024 Q3 81 92.2 M $170 M
2024 Q2 85 93.1 M $93.6 M
2024 Q1 82 94.9 M $188 M
2023 Q4 81 86.6 M $135 M
2023 Q3 78 89.7 M $177 M
2023 Q2 74 90.5 M $288 M
2023 Q1 74 81.5 M $267 M
2022 Q4 57 80.1 M $403 M
2022 Q3 40 67.4 M $154 M
2022 Q2 35 61.9 M $164 M
2022 Q1 35 62.4 M $85.4 M
2021 Q4 38 63.6 M $202 M